References
- Wu SJ, Du X, Chen YX, Jiang WL, Zhong LY, Lin W, Huang ZL. Relationship between cyclins and prognosis of acute leukemia. Ai Zheng 2003;22:852–855.
- Ewen ME, Lamb J. The activities of cyclin D1 that drive tumorigenesis. Trends Mol Med 2004;10:158–162.
- Stendahl M, Kronblad A, Ryden L, Emdin S, Bengtsson NO, Landberg G. Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer 200490:1942-1948.
- Barbieri F, Lorenzi P, Ragni N, Schettini G, Bruzzo C, Pedulla F, Alama A. Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer. Oncology 2004;66: 310–315.
- Ikehara M, Oshita F, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A, Kameda Y. Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung. Oncol Rep 2003;10:137–139.
- Xu JM, Wen JM, Zhang M, Lu GL, Wu LZ, Wang WS. A study of gene amplification and expression of cyclin D1 in hepatocellular carcinoma. Zhonghua Bing Li Xue Za Zhi 2004;33:26–30.
- Specht K, Haralambieva E, Bink K, Kremer M, Mandl-Weber S, Koch I, Tomer R, Hofler H, Schuuring E, Kluin PM, Fend F, Quintanilla-Martinez L. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 2004;104: 1120–1126.
- Katayama Y, Sakai A, Okikawa Y, Oue N, Asaoku H, Sasaki A, Imanaka F, Tsujimoto T, Takimoto Y, Masuda R, Nakaju N, Otsuki T, Yasui W, Kimura A. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells. Int J Oncol 2004;25:579–595.
- Elnenaei MO, Jadayel DM, Matutes E, Morilla R, Owusu-Ankomah K, Atkinson S, Titley I, Mandala EM, Catovsky D. Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. Leuk Res 2001;25: 115–123.
- Sauerbrey A, Hafer R, Zintl F, Volm M. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Res 1999;19:645–649.
- Volm M, Koomagi R, Stammler G, Rittgen W, Zinl F, Sauebrey A. Prognostic implications of cyclins (D1,E,A), cyclin-dependent kinases (CDK2, CDK4) and tumor-sup-pressor genes (PRB, P161NK4A) in childhood acute lymphoblastic leukemia. Int J Cancer 1997;74:508–512.
- Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin Dl: normal and abnormal functions. Endocrinology 2004;145(12):5439–5447.
- Diehl JA. Cycling to cancer with cyclin Dl. Cancer Biol Ther 2002;1:226–231.